Envista Holdings (NVST) Capital Expenditures Growth (1y) (2019 - 2026)
Envista Holdings (NVST) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.65% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -2.04% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 61.83% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -63.39% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.63% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.73% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.30% |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 111.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 111.86% |
| Dec 31, 2025 | 89.53% |
| Sep 26, 2025 | 45.95% |
| Jun 27, 2025 | 80.88% |
| Mar 28, 2025 | -46.36% |
| Dec 31, 2024 | 4.88% |
| Sep 27, 2024 | -59.78% |
| Jun 28, 2024 | -51.77% |
| Mar 29, 2024 | -37.14% |
| Dec 31, 2023 | -51.48% |
| Sep 29, 2023 | -31.60% |
| Jun 30, 2023 | 16.53% |
| Mar 31, 2023 | -11.62% |
| Dec 31, 2022 | 94.25% |
| Sep 30, 2022 | 53.71% |
| Jul 1, 2022 | -40.10% |
| Apr 1, 2022 | 138.55% |
| Dec 31, 2021 | -33.59% |
| Oct 1, 2021 | 32.58% |
| Jul 2, 2021 | 158.97% |